Search

everythinglearnresearchcommunity

for

Search:↓

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Copper may protect against alopecia areata, while certain inflammatory markers increase risk.

The research updated the skin cell profile, finding new skin cell markers and showing fibroblasts' key role in skin health.

Hemp seed biomaterials may reduce hair loss and improve hair growth.

Mitochondrial dysfunction may contribute to chronic inflammation and immune system issues in Lichen planopilaris.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Camelina oil can improve dog coat quality like flaxseed and canola oils.

Immune privilege collapse in hair follicles may cause permanent hair loss in certain conditions.

The study found that sweat glands normally suppress immune responses, but this is disrupted in certain skin diseases, possibly contributing to their development.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

KLB and EIF3C genes are key for early diagnosis of vitiligo and alopecia areata.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

CLEC10A and interleukin-42 can help identify PCOS patients' response to Metformin treatment.

Cyclosporin A is highly toxic to rats, causing severe health issues and death.

Restoring hair follicle immune privilege may help treat alopecia areata.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

PCOS is linked to inflammation, and certain markers could help in its treatment.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

JAK inhibitors are effective treatments for alopecia areata.

Netherton syndrome can cause severe dehydration, infections, and growth issues in infants.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Tigers had a skin condition causing hair loss and inflammation, but the cause is unknown and treatment didn't work.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Microorganism overgrowth and hyperkeratosis may trigger immune reactions causing lichen planopilaris.

It's unclear if cell-based therapies from lipoaspirate devices improve clinical outcomes due to inconsistent data.

Targeting TRP channels may help reduce excessive scarring.